In 2025, India overtook China as the world's most populous country and now has almost 1.46 billion people. China now has the second-largest population in the world, still with just over 1.4 billion inhabitants, however, its population went into decline in 2023. Global population As of 2025, the world's population stands at almost 8.2 billion people and is expected to reach around 10.3 billion people in the 2080s, when it will then go into decline. Due to improved healthcare, sanitation, and general living conditions, the global population continues to increase; mortality rates (particularly among infants and children) are decreasing and the median age of the world population has steadily increased for decades. As for the average life expectancy in industrial and developing countries, the gap has narrowed significantly since the mid-20th century. Asia is the most populous continent on Earth; 11 of the 20 largest countries are located there. It leads the ranking of the global population by continent by far, reporting four times as many inhabitants as Africa. The Demographic Transition The population explosion over the past two centuries is part of a phenomenon known as the demographic transition. Simply put, this transition results from a drastic reduction in mortality, which then leads to a reduction in fertility, and increase in life expectancy; this interim period where death rates are low and birth rates are high is where this population explosion occurs, and population growth can remain high as the population ages. In today's most-developed countries, the transition generally began with industrialization in the 1800s, and growth has now stabilized as birth and mortality rates have re-balanced. Across less-developed countries, the stage of this transition varies; for example, China is at a later stage than India, which accounts for the change in which country is more populous - understanding the demographic transition can help understand the reason why China's population is now going into decline. The least-developed region is Sub-Saharan Africa, where fertility rates remain close to pre-industrial levels in some countries. As these countries transition, they will undergo significant rates of population growth.

In 2023, it is estimated that the BRICS countries have a combined population of 3.25 billion people, which is over 40 percent of the world population. The majority of these people live in either China or India, which have a population of more than 1.4 billion people each, while the other three countries have a combined population of just under 420 million. Comparisons Although the BRICS countries are considered the five foremost emerging economies, they are all at various stages of the demographic transition and have different levels of population development. For all of modern history, China has had the world's largest population, but rapidly dropping fertility and birth rates in recent decades mean that its population growth has slowed. In contrast, India's population growth remains much higher, and it is expected to overtake China in the next few years to become the world's most populous country. The fastest growing population in the BRICS bloc, however, is that of South Africa, which is at the earliest stage of demographic development. Russia, is the only BRICS country whose population is currently in decline, and it has been experiencing a consistent natural decline for most of the past three decades. Growing populations = growing opportunities Between 2000 and 2026, the populations of the BRICS countries is expected to grow by 625 million people, and the majority of this will be in India and China. As the economies of these two countries grow, so too do living standards and disposable income; this has resulted in the world's two most populous countries emerging as two of the most profitable markets in the world. China, sometimes called the "world's factory" has seen a rapid growth in its middle class, increased potential of its low-tier market, and its manufacturing sector is now transitioning to the production of more technologically advanced and high-end goods to meet its domestic demand.

From now until 2100, India and China will remain the most populous countries in the world, however China's population decline has already started, and it is on course to fall by around 50 percent in the 2090s; while India's population decline is projected to begin in the 2060s. Of the 10 most populous countries in the world in 2100, five will be located in Asia, four in Africa, as well as the United States. Rapid growth in Africa Rapid population growth across Africa will see the continent's population grow from around 1.5 billion people in 2024 to 3.8 billion in 2100. Additionally, unlike China or India, population growth in many of these countries is not expected to go into decline, and instead is expected to continue well into the 2100s. Previous estimates had projected these countries' populations would be much higher by 2100 (the 2019 report estimated Nigeria's population would exceed 650 million), yet the increased threat of the climate crisis and persistent instability is delaying demographic development and extending population growth. The U.S. as an outlier Compared to the nine other largest populations in 2100, the United States stands out as it is more demographically advanced, politically stable, and economically stronger. However, while most other so-called "advanced countries" are projected to see their population decline drastically in the coming decades, the U.S. population is projected to continue growing into the 2100s. This will largely be driven by high rates of immigration into the U.S., which will drive growth despite fertility rates being around 1.6 births per woman (below the replacement level of 2.1 births per woman), and the slowing rate of life expectancy. Current projections estimate the U.S. will have a net migration rate over 1.2 million people per year for the remainder of the century.

IntroductionThe combined populations of China and India were 2.78 billion in 2020, representing 36% of the world population (7.75 billion). Wheat is the second most important staple grain in both China and India. In 2019, the aggregate wheat consumption in China was 96.4 million ton and in India it was 82.5 million ton, together it was more than 35% of the world's wheat that year. In China, in 2050, the projected population will be 1294–1515 million, and in India, it is projected to be 14.89–1793 million, under the low and high-fertility rate assumptions. A question arises as to, what will be aggregate demand for wheat in China and India in 2030 and 2050?MethodsApplying the Vector Error Correction model estimation process in the time series econometric estimation setting, this study projected the per capita and annual aggregate wheat consumptions of China and India during 2019-2050. In the process, this study relies on agricultural data sourced from the Food and Agriculture Organization of the United States (FAO) database (FAOSTAT), as well as the World Bank's World Development Indicators (WDI) data catalog. The presence of unit root in the data series are tested by applying the augmented Dickey-Fuller test; Philips-Perron unit root test; Kwiatkowski-Phillips-Schmidt-Shin test, and Zivot-Andrews Unit Root test allowing for a single break in intercept and/or trend. The test statistics suggest that a natural log transformation and with the first difference of the variables provides stationarity of the data series for both China and India. The Zivot-Andrews Unit Root test, however, suggested that there is a structural break in urban population share and GDP per capita. To tackle the issue, we have included a year dummy and two multiplicative dummies in our model. Furthermore, the Johansen cointegration test suggests that at least one variable in both data series were cointegrated. These tests enable us to apply Vector Error Correction (VEC) model estimation procedure. In estimation the model, the appropriate number of lags of the variables is confirmed by applying the “varsoc” command in Stata 17 software interface. The estimated yearly per capita wheat consumption in 2030 and 2050 from the VEC model, are multiplied by the projected population in 2030 and 2050 to calculate the projected aggregate wheat demand in China and India in 2030 and 2050. After projecting the yearly per capita wheat consumption (KG), we multiply with the projected population to get the expected consumption demand.ResultsThis study found that the yearly per capita wheat consumption of China will increase from 65.8 kg in 2019 to 76 kg in 2030, and 95 kg in 2050. In India, the yearly per capita wheat consumption will increase to 74 kg in 2030 and 94 kg in 2050 from 60.4 kg in 2019. Considering the projected population growth rates under low-fertility assumptions, aggregate wheat consumption of China will increase by more than 13% in 2030 and by 28% in 2050. Under the high-fertility rate assumption, however the aggregate wheat consumption of China will increase by 18% in 2030 and nearly 50% in 2050. In the case of India, under both low and high-fertility rate assumptions, aggregate wheat demand in India will increase by 32-38% in 2030 and by 70-104% in 2050 compared to 2019 level of consumption.DiscussionsOur results underline the importance of wheat in both countries, which are the world's top wheat producers and consumers, and suggest the importance of research and development investments to maintain sufficient national wheat grain production levels to meet China and India's domestic demand. This is critical both to ensure the food security of this large segment of the world populace, which also includes 23% of the total population of the world who live on less than US $1.90/day, as well as to avoid potential grain market destabilization and price hikes that arise in the event of large import demands.

According to latest figures, the Chinese population decreased by 1.39 million to around 1.408 billion people in 2024. After decades of rapid growth, China arrived at the turning point of its demographic development in 2022, which was earlier than expected. The annual population decrease is estimated to remain at moderate levels until around 2030 but to accelerate thereafter. Population development in China China had for a long time been the country with the largest population worldwide, but according to UN estimates, it has been overtaken by India in 2023. As the population in India is still growing, the country is very likely to remain being home of the largest population on earth in the near future. Due to several mechanisms put into place by the Chinese government as well as changing circumstances in the working and social environment of the Chinese people, population growth has subsided over the past decades, displaying an annual population growth rate of -0.1 percent in 2024. Nevertheless, compared to the world population in total, China held a share of about 17 percent of the overall global population in 2024. China's aging population In terms of demographic developments, the birth control efforts of the Chinese government had considerable effects on the demographic pyramid in China. Upon closer examination of the age distribution, a clear trend of an aging population becomes visible. In order to curb the negative effects of an aging population, the Chinese government abolished the one-child policy in 2015, which had been in effect since 1979, and introduced a three-child policy in May 2021. However, many Chinese parents nowadays are reluctant to have a second or third child, as is the case in most of the developed countries in the world. The number of births in China varied in the years following the abolishment of the one-child policy, but did not increase considerably. Among the reasons most prominent for parents not having more children are the rising living costs and costs for child care, growing work pressure, a growing trend towards self-realization and individualism, and changing social behaviors.

According to the 2010 UN Global Demographic Outlook, the world’s population reached 7.1 billion as of 1 July 2012. Asia accounted for the majority of the world’s population (just over 60 % in 2012), with 4.25 billion inhabitants, while Africa was the second most populous continent, with 1.07 billion inhabitants, or 15.2 % of the world’s total. By comparison, the EU had 504 million inhabitants in 2012, just over 7 % of the world’s population. In 2012, the world’s most populous countries were China (19.2 % of the world’s population) and India (17.8 %), followed by the United States (4.5 %), Indonesia (3.5 %) and Brazil (2.8 %).

The table contains the demographic projections of the main European countries from 2020 to 2080. The Eurostat table has been modified by economy-policy in order to obtain better visibility. Indeed, the number of inhabitants is expressed in “million inhabitants” and not in unit data.
In addition, demographic projections for China, India, Brazil and Russia were added for the years 2030, 2040 and 2050.

Graph and download economic data for Population, Total for China (POPTOTCNA647NWDB) from 1960 to 2024 about China and population.

Research investigates possible influence of population growth on per capita income growth in China and India from 1980 to 2020.

The statistic shows the total population of India from 2019 to 2029. In 2023, the estimated total population in India amounted to approximately 1.43 billion people.

Total population in India

India currently has the second-largest population in the world and is projected to overtake top-ranking China within forty years. Its residents comprise more than one-seventh of the entire world’s population, and despite a slowly decreasing fertility rate (which still exceeds the replacement rate and keeps the median age of the population relatively low), an increasing life expectancy adds to an expanding population. In comparison with other countries whose populations are decreasing, such as Japan, India has a relatively small share of aged population, which indicates the probability of lower death rates and higher retention of the existing population.

With a land mass of less than half that of the United States and a population almost four times greater, India has recognized potential problems of its growing population. Government attempts to implement family planning programs have achieved varying degrees of success. Initiatives such as sterilization programs in the 1970s have been blamed for creating general antipathy to family planning, but the combined efforts of various family planning and contraception programs have helped halve fertility rates since the 1960s. The population growth rate has correspondingly shrunk as well, but has not yet reached less than one percent growth per year.

As home to thousands of ethnic groups, hundreds of languages, and numerous religions, a cohesive and broadly-supported effort to reduce population growth is difficult to create. Despite that, India is one country to watch in coming years. It is also a growing economic power; among other measures, its GDP per capita was expected to triple between 2003 and 2013 and was listed as the third-ranked country for its share of the global gross domestic product.

Explore World Bank Health, Nutrition and Population Statistics dataset featuring a wide range of indicators such as School enrollment, UHC service coverage index, Fertility rate, and more from countries like Bahrain, China, India, Kuwait, Oman, Qatar, and Saudi Arabia.

School enrollment, tertiary, UHC service coverage index, Wanted fertility rate, People with basic handwashing facilities, urban population, Rural population, AIDS estimated deaths, Domestic private health expenditure, Fertility rate, Domestic general government health expenditure, Age dependency ratio, Postnatal care coverage, People using safely managed drinking water services, Unemployment, Lifetime risk of maternal death, External health expenditure, Population growth, Completeness of birth registration, Urban poverty headcount ratio, Prevalence of undernourishment, People using at least basic sanitation services, Prevalence of current tobacco use, Urban poverty headcount ratio, Tuberculosis treatment success rate, Low-birthweight babies, Female headed households, Completeness of birth registration, Urban population growth, Antiretroviral therapy coverage, Labor force, and more.

Bahrain, China, India, Kuwait, Oman, Qatar, Saudi Arabia

Follow data.kapsarc.org for timely data to advance energy economics research.

The Global Non-Stick Cookware market size will be $13,628.21 Million by 2028. The Global Non-Stick Cookware Industry's Compound Annual Growth Rate will be 3.73% from 2023 to 2030.

Explore the Saudi Arabia World Development Indicators dataset , including key indicators such as Access to clean fuels, Adjusted net enrollment rate, CO2 emissions, and more. Find valuable insights and trends for Saudi Arabia, Bahrain, Kuwait, Oman, Qatar, China, and India.

Indicator, Access to clean fuels and technologies for cooking, rural (% of rural population), Access to electricity (% of population), Adjusted net enrollment rate, primary, female (% of primary school age children), Adjusted net national income (annual % growth), Adjusted savings: education expenditure (% of GNI), Adjusted savings: mineral depletion (current US$), Adjusted savings: natural resources depletion (% of GNI), Adjusted savings: net national savings (current US$), Adolescents out of school (% of lower secondary school age), Adolescents out of school, female (% of female lower secondary school age), Age dependency ratio (% of working-age population), Agricultural methane emissions (% of total), Agriculture, forestry, and fishing, value added (current US$), Agriculture, forestry, and fishing, value added per worker (constant 2015 US$), Alternative and nuclear energy (% of total energy use), Annualized average growth rate in per capita real survey mean consumption or income, total population (%), Arms exports (SIPRI trend indicator values), Arms imports (SIPRI trend indicator values), Average working hours of children, working only, ages 7-14 (hours per week), Average working hours of children, working only, male, ages 7-14 (hours per week), Cause of death, by injury (% of total), Cereal yield (kg per hectare), Changes in inventories (current US$), Chemicals (% of value added in manufacturing), Child employment in agriculture (% of economically active children ages 7-14), Child employment in manufacturing, female (% of female economically active children ages 7-14), Child employment in manufacturing, male (% of male economically active children ages 7-14), Child employment in services (% of economically active children ages 7-14), Child employment in services, female (% of female economically active children ages 7-14), Children (ages 0-14) newly infected with HIV, Children in employment, study and work (% of children in employment, ages 7-14), Children in employment, unpaid family workers (% of children in employment, ages 7-14), Children in employment, wage workers (% of children in employment, ages 7-14), Children out of school, primary, Children out of school, primary, male, Claims on other sectors of the domestic economy (annual growth as % of broad money), CO2 emissions (kg per 2015 US$ of GDP), CO2 emissions (kt), CO2 emissions from other sectors, excluding residential buildings and commercial and public services (% of total fuel combustion), CO2 emissions from transport (% of total fuel combustion), Communications, computer, etc. (% of service exports, BoP), Condom use, population ages 15-24, female (% of females ages 15-24), Container port traffic (TEU: 20 foot equivalent units), Contraceptive prevalence, any method (% of married women ages 15-49), Control of Corruption: Estimate, Control of Corruption: Percentile Rank, Upper Bound of 90% Confidence Interval, Control of Corruption: Standard Error, Coverage of social insurance programs in 4th quintile (% of population), CPIA building human resources rating (1=low to 6=high), CPIA debt policy rating (1=low to 6=high), CPIA policies for social inclusion/equity cluster average (1=low to 6=high), CPIA public sector management and institutions cluster average (1=low to 6=high), CPIA quality of budgetary and financial management rating (1=low to 6=high), CPIA transparency, accountability, and corruption in the public sector rating (1=low to 6=high), Current education expenditure, secondary (% of total expenditure in secondary public institutions), DEC alternative conversion factor (LCU per US$), Deposit interest rate (%), Depth of credit information index (0=low to 8=high), Diarrhea treatment (% of children under 5 who received ORS packet), Discrepancy in expenditure estimate of GDP (current LCU), Domestic private health expenditure per capita, PPP (current international $), Droughts, floods, extreme temperatures (% of population, average 1990-2009), Educational attainment, at least Bachelor's or equivalent, population 25+, female (%) (cumulative), Educational attainment, at least Bachelor's or equivalent, population 25+, male (%) (cumulative), Educational attainment, at least completed lower secondary, population 25+, female (%) (cumulative), Educational attainment, at least completed primary, population 25+ years, total (%) (cumulative), Educational attainment, at least Master's or equivalent, population 25+, male (%) (cumulative), Educational attainment, at least Master's or equivalent, population 25+, total (%) (cumulative), Electricity production from coal sources (% of total), Electricity production from nuclear sources (% of total), Employers, total (% of total employment) (modeled ILO estimate), Employment in industry (% of total employment) (modeled ILO estimate), Employment in services, female (% of female employment) (modeled ILO estimate), Employment to population ratio, 15+, male (%) (modeled ILO estimate), Employment to population ratio, ages 15-24, total (%) (national estimate), Energy use (kg of oil equivalent per capita), Export unit value index (2015 = 100), Exports of goods and services (% of GDP), Exports of goods, services and primary income (BoP, current US$), External debt stocks (% of GNI), External health expenditure (% of current health expenditure), Female primary school age children out-of-school (%), Female share of employment in senior and middle management (%), Final consumption expenditure (constant 2015 US$), Firms expected to give gifts in meetings with tax officials (% of firms), Firms experiencing losses due to theft and vandalism (% of firms), Firms formally registered when operations started (% of firms), Fixed broadband subscriptions, Fixed telephone subscriptions (per 100 people), Foreign direct investment, net outflows (% of GDP), Forest area (% of land area), Forest area (sq. km), Forest rents (% of GDP), GDP growth (annual %), GDP per capita (constant LCU), GDP per unit of energy use (PPP $ per kg of oil equivalent), GDP, PPP (constant 2017 international $), General government final consumption expenditure (current LCU), GHG net emissions/removals by LUCF (Mt of CO2 equivalent), GNI growth (annual %), GNI per capita (constant LCU), GNI, PPP (current international $), Goods and services expense (current LCU), Government Effectiveness: Percentile Rank, Government Effectiveness: Percentile Rank, Lower Bound of 90% Confidence Interval, Government Effectiveness: Standard Error, Gross capital formation (annual % growth), Gross capital formation (constant 2015 US$), Gross capital formation (current LCU), Gross fixed capital formation, private sector (% of GDP), Gross intake ratio in first grade of primary education, male (% of relevant age group), Gross intake ratio in first grade of primary education, total (% of relevant age group), Gross national expenditure (current LCU), Gross national expenditure (current US$), Households and NPISHs Final consumption expenditure (constant LCU), Households and NPISHs Final consumption expenditure (current US$), Households and NPISHs Final consumption expenditure, PPP (constant 2017 international $), Households and NPISHs final consumption expenditure: linked series (current LCU), Human capital index (HCI) (scale 0-1), Human capital index (HCI), male (scale 0-1), Immunization, DPT (% of children ages 12-23 months), Import value index (2015 = 100), Imports of goods and services (% of GDP), Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24), Incidence of HIV, all (per 1,000 uninfected population), Income share held by highest 20%, Income share held by lowest 20%, Income share held by third 20%, Individuals using the Internet (% of population), Industry (including construction), value added (constant LCU), Informal payments to public officials (% of firms), Intentional homicides, male (per 100,000 male), Interest payments (% of expense), Interest rate spread (lending rate minus deposit rate, %), Internally displaced persons, new displacement associated with conflict and violence (number of cases), International tourism, expenditures for passenger transport items (current US$), International tourism, expenditures for travel items (current US$), Investment in energy with private participation (current US$), Labor force participation rate for ages 15-24, female (%) (modeled ILO estimate), Development

Saudi Arabia, Bahrain, Kuwait, Oman, Qatar, China, India Follow data.kapsarc.org for timely data to advance energy economics research..

In 2024, Germany was the leading EU country in terms of population, with around 85 million inhabitants. In 2050, approximately 89.2 million people will live in Germany, according to the forecast. See the total EU population figures for more information. The global population The global population is rapidly increasing. Between 1990 and 2015, it increased by around 2 billion people. Furthermore, it is estimated that the global population will have increased by another 1 billion by 2030. Asia is the continent with the largest population, followed by Africa and Europe. In Asia,the two most populous nations worldwide are located, China and India. In 2014, the combined population in China and India alone amounted to more than 2.6 billion people. for comparison, the total population in the whole continent of Europe is at around 741 million people. As of 2014, about 60 percent of the global population was living in Asia, with only approximately 10 percent in Europe and even less in the United States. Europe is the continent with the second-highest life expectancy at birth in the world, only barely surpassed by Northern America. In 2013, the life expectancy at birth in Europe was around 78 years. Stable economies and developing and emerging markets in European countries provide for good living conditions. Seven of the top twenty countries in the world with the largest gross domestic product in 2015 are located in Europe.

Snapshot img

Benign Prostatic Hyperplasia Surgical Treatment Market Size 2025-2029

The benign prostatic hyperplasia surgical treatment market is projected to grow by USD 4.9 million, exhibiting a CAGR of 5.1% during the forecast period. Access precise market valuations upon report purchase. The global benign prostatic hyperplasia surgical treatment market is propelled by the expanding aging population and the increasing prevalence of benign prostatic hyperplasia (BPH). This condition, characterized by the enlargement of the prostate gland, leads to significant demand for surgical interventions. The rising incidence of obesity in males, closely associated with BPH, further fuels market growth. While minimally invasive surgeries gain preference for their reduced recovery times and fewer complications, the high growth potential of emerging economies and favorable funding for BPH drug development also shape the market landscape.

To access the full market forecast and comprehensive analysis, Buy Now

How is this market segmented?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in USD bn for the period 2025-2029, as well as historical data from 2019-2024 for the following segments:

Drug Type

  Alpha-blockers
  5-Alpha Reductase Inhibitors
  Other Drug Types


Type

  Transurethral Resection of the Prostate (TURP)
  Laser Surgeries
  Urolift Procedures
  Rezum Procedures
  Other Procedures


Therapy

  Monotherapy
  Combination Drug Therapy


End User

  Hospitals
  Ambulatory Surgery Centers & Clinics
  Home Care Settings


APAC

  China
  India
  Japan
  Australia
  Rest of APAC

Europe


  Germany
  Spain
  Italy
  UK
  Rest of Europe

North America


  US
  Canada

South America & MEA


  Brazil
  UAE
  South Africa
  Others





Type

  Laser Surgeries: Laser surgeries are gaining traction due to their minimally invasive nature and reduced recovery time.
  Other Procedures: Other procedures include various alternative and emerging techniques, contributing to market innovation.
  Rezum Procedures: Rezum procedures are gaining popularity due to their ability to provide targeted treatment with minimal side effects.
  Urolift Procedures: Urolift procedures are expected to see growth as a less invasive option with minimal impact on sexual function.
  Transurethral Resection of the Prostate (TURP): TURP remains a widely used surgical method and a significant market segment.


Therapy

  Monotherapy: Monotherapy remains a common treatment approach, particularly for initial management of BPH symptoms.
  Combination Drug Therapy: Combination drug therapy is used for patients requiring more aggressive symptom management.


End User

  Hospitals: Hospitals are a major end-user segment, providing a wide range of surgical and medical treatments for BPH.
  Home Care Settings: Home care settings are growing due to the increasing use of oral medications and remote monitoring.
  Ambulatory Surgery Centers & Clinics: Ambulatory surgery centers and clinics offer cost-effective and convenient settings for BPH procedures.


Drug Type

  Alpha-blockers: This segment maintains a substantial market share due to its efficacy in managing BPH symptoms.
  Other Drug Types: This segment includes combination therapies and emerging drugs, anticipated to show growth due to tailored treatment approaches.
  5-Alpha Reductase Inhibitors: The 5-alpha reductase inhibitors segment is expected to grow as a treatment option for reducing prostate size.

Regional Analysis

APAC: The Asia-Pacific region is expected to exhibit the highest growth rate In the benign prostatic hyperplasia surgical treatment market. This is primarily attributed to the presence of a large target patient population in China and India, coupled with improving healthcare infrastructure and increasing awareness regarding BPH treatment options. Rapid economic development and rising healthcare expenditure In these countries are also significant factors driving market growth. Furthermore, the expanding geriatric population and favorable government initiatives aimed at enhancing treatment accessibility contribute to the region's growth momentum.
Europe: Europe holds a substantial share in the benign prostatic hyperplasia surgical treatment market, with Germany and the UK being key contributors. The region's growth is driven by a well-established healthcare system, high awareness levels among the population, and the availability of advanced treatment technologies. The presence of major market players and favorable reimbursement policies further support market expansion. Additionally, a strong focus on research and development activities contributes to the introduction of innovative surgical techniques and devices.
North America: North America dominates the benign prostatic hyperplasia surgical treatment market d

The graph shows the population growth in China from 2000 to 2024. In 2024, the Chinese population decreased by about 0.1 percent or 1.39 million to around 1.408 billion people. Declining population growth in China Due to strict birth control measures by the Chinese government as well as changing family and work situations of the Chinese people, population growth has subsided over the past decades. Although the gradual abolition of the one-child policy from 2014 on led to temporarily higher birth figures, growth rates further decreased in recent years. As of 2024, leading countries in population growth could almost exclusively be found on the African continent and the Arabian Peninsula. Nevertheless, as of mid 2024, Asia ranked first by a wide margin among the continents in terms of absolute population. Future development of Chinese population The Chinese population reached a maximum of 1,412.6 million people in 2021 but decreased by 850,000 in 2022 and another 2.08 million in 2023. Until 2022, China had still ranked the world’s most populous country, but it was overtaken by India in 2023. Apart from the population decrease, a clear growth trend in Chinese cities is visible. By 2024, around 67 percent of Chinese people lived in urban areas, compared to merely 36 percent in 2000.

Use this application to view the pattern of concentrations of people by race and Hispanic or Latino ethnicity. Data are provided at the U.S. Census block group level, one of the smallest Census geographies, to provide a detailed picture of these patterns. The data is sourced from the U.S Census Bureau, 2020 Census Redistricting Data (Public Law 94-171) Summary File. Definitions: Definitions of the Census Bureau’s categories are provided below. This interactive map shows patterns for all categories except American Indian or Alaska Native and Native Hawaiian or Other Pacific Islander. The total population countywide for these two categories is small (1,582 and 263 respectively). The Census Bureau uses the following race categories:Population by RaceWhite – A person having origins in any of the original peoples of Europe, the Middle East, or North Africa.Black or African American – A person having origins in any of the Black racial groups of Africa.American Indian or Alaska Native – A person having origins in any of the original peoples of North and South America (including Central America) and who maintains tribal affiliation or community attachment.Asian – A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam.Native Hawaiian or Other Pacific Islander – A person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands.Some Other Race - this category is chosen by people who do not identify with any of the categories listed above. People can identify with more than one race. These people are included in the Two or More Races Hispanic or Latino PopulationThe Hispanic/Latino population is an ethnic group. Hispanic/Latino people may be of any race.Other layers provided in this tool included the Loudoun County Census block groups, towns and Dulles airport, and the Loudoun County 2021 aerial imagery.

The Country-Level Population and Downscaled Projections Based on Special Report on Emissions Scenarios (SRES) B2 Scenario, 1990-2100, were based on the UN 1998 Medium Long Range Projection for the years 1995 to 2100. The official version projects population for 8 regions of the world including Africa, Asia (minus India and China), India, China, Europe, Latin America, Northern America, and Oceania. This data set is produced and distributed by the Columbia University Center for International Earth Science Information Network (CIESIN).

The region of present-day China has historically been the most populous region in the world; however, its population development has fluctuated throughout history. In 2022, China was overtaken as the most populous country in the world, and current projections suggest its population is heading for a rapid decline in the coming decades. Transitions of power lead to mortality The source suggests that conflict, and the diseases brought with it, were the major obstacles to population growth throughout most of the Common Era, particularly during transitions of power between various dynasties and rulers. It estimates that the total population fell by approximately 30 million people during the 14th century due to the impact of Mongol invasions, which inflicted heavy losses on the northern population through conflict, enslavement, food instability, and the introduction of bubonic plague. Between 1850 and 1870, the total population fell once more, by more than 50 million people, through further conflict, famine and disease; the most notable of these was the Taiping Rebellion, although the Miao an Panthay Rebellions, and the Dungan Revolt, also had large death tolls. The third plague pandemic also originated in Yunnan in 1855, which killed approximately two million people in China. 20th and 21st centuries There were additional conflicts at the turn of the 20th century, which had significant geopolitical consequences for China, but did not result in the same high levels of mortality seen previously. It was not until the overlapping Chinese Civil War (1927-1949) and Second World War (1937-1945) where the death tolls reached approximately 10 and 20 million respectively. Additionally, as China attempted to industrialize during the Great Leap Forward (1958-1962), economic and agricultural mismanagement resulted in the deaths of tens of millions (possibly as many as 55 million) in less than four years, during the Great Chinese Famine. This mortality is not observable on the given dataset, due to the rapidity of China's demographic transition over the entire period; this saw improvements in healthcare, sanitation, and infrastructure result in sweeping changes across the population. The early 2020s marked some significant milestones in China's demographics, where it was overtaken by India as the world's most populous country, and its population also went into decline. Current projections suggest that China is heading for a "demographic disaster", as its rapidly aging population is placing significant burdens on China's economy, government, and society. In stark contrast to the restrictive "one-child policy" of the past, the government has introduced a series of pro-fertility incentives for couples to have larger families, although the impact of these policies are yet to materialize. If these current projections come true, then China's population may be around half its current size by the end of the century.

Consumer Luxury Goods Market Outlook

As of 2023, the global market size for consumer luxury goods is estimated to be approximately $350 billion. With a compound annual growth rate (CAGR) of 6% from 2024 to 2032, the market is projected to reach $550 billion by 2032. The anticipated growth is driven by rising disposable incomes, the development of global retail channels, and an increasing inclination towards exclusive and premium products among consumers worldwide.

The growth of the consumer luxury goods market is heavily influenced by the escalating disposable incomes in emerging economies. As countries like China, India, and Brazil witness rapid economic development, their middle and upper-middle-class populations are expanding. These demographic segments have a growing appetite for luxury goods, driven by a combination of increasing wealth and a desire for social status. The aspirational aspect of luxury goods, coupled with the growing influence of Western lifestyles and fashion trends, further propels market growth in these regions.

The proliferation of digital platforms and e-commerce has also significantly contributed to the market's expansion. Online channels have democratized access to luxury goods, making them available to consumers in remote and previously untapped markets. Internet penetration and smartphone usage have surged globally, enabling consumers to explore and purchase high-end products from the comfort of their homes. Luxury brands are increasingly investing in enhancing their digital presence, through virtual showrooms and personalized online shopping experiences, thereby broadening their customer base and driving sales.

Another pivotal factor bolstering market growth is the shifting consumer preference towards experiences over material possessions. Millennials and Generation Z, in particular, are veering towards experiential luxury, which includes high-end travel, fine dining, and bespoke services. This trend has compelled luxury brands to diversify their offerings and focus on creating unique, memorable experiences for their customers. Consequently, brands are not only selling products but also curating immersive brand experiences that foster customer loyalty and engagement.

Luxury Item Retail Websites have become pivotal in shaping the modern luxury goods market. These platforms offer an unparalleled level of convenience and accessibility, allowing consumers to explore and purchase luxury items from anywhere in the world. The rise of these websites has not only expanded the reach of luxury brands but also provided a platform for smaller, niche brands to gain visibility. With features like virtual try-ons, personalized recommendations, and exclusive online collections, luxury item retail websites are redefining the shopping experience. They cater to a tech-savvy audience that values both the prestige of luxury goods and the ease of online shopping. As a result, these websites are playing a crucial role in driving sales and enhancing brand loyalty in the digital age.

Regionally, North America and Europe continue to dominate the consumer luxury goods market, owing to their established economies and high levels of disposable income. However, the Asia Pacific region is emerging as a significant growth driver, with China and India at the forefront. The increasing affluence in these countries, combined with a burgeoning young population and rising brand consciousness, presents lucrative opportunities for luxury brands. Meanwhile, the Middle East and Africa, though smaller in market size, are showing promising growth trajectories due to the rising number of high-net-worth individuals and the popularity of luxury tourism in the region.

Product Type Analysis

The consumer luxury goods market is segmented into various product types including apparel, accessories, watches and jewelry, cosmetics and fragrances, wines and spirits, and others. Apparel holds a significant share in the market, driven by the perpetual demand for high-quality, fashionable clothing. Leading brands such as Gucci, Louis Vuitton, and Chanel dominate this segment, continually setting trends and catering to the elite's sartorial preferences. The emphasis on craftsmanship, exclusivity, and brand heritage plays a crucial role in sustaining the allure of luxury apparel among affluent consumers.

Accessories, encompassing items such as handbags, shoes, and small leather goods, represent another lucrative segment

Snapshot img

Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size 2025-2029

The diffuse large B-Cell lymphoma (DLBCL) therapeutics market size is forecast to increase by USD 2.46 billion, at a CAGR of 8.2% between 2024 and 2029.

The market is experiencing significant growth, driven primarily by the increasing geriatric population and advancements in technology. The aging demographic is a key factor, as DLBCL is more prevalent in older adults, making up up to 50% of all non-Hodgkin lymphoma diagnoses in this age group. Cell therapy manufacturing and precision medicine are emerging trends, with CAR T-cell therapy and stem cell transplantation offering promising results for refractory DLBCL patients. Moreover, technological innovations are transforming the treatment landscape, with a trend toward less invasive, targeted therapies and the development of new drugs with improved cytotoxicity.
Companies seeking to capitalize on market opportunities must navigate these challenges by investing in research and development of less toxic therapies and exploring alternative treatment modalities. Additionally, collaboration with regulatory bodies and patient advocacy groups can help ensure the availability and accessibility of effective treatments for this patient population. However, challenges remain, including the cytotoxicity of current drugs and the inclination toward radiation treatments, which can have significant side effects and limit patient compliance. Clinical trial recruitment is streamlined through digital health technologies and patient registries, enabling cost-effective analysis and real-world data collection.

What will be the Size of the Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market during the forecast period?

Request Free Sample

The market is experiencing significant advancements, driven by the integration of value-based healthcare and innovative technologies. Antibody-drug conjugates (ADCs) and immunomodulatory drugs are at the forefront of this evolution, targeting specific cell signaling pathways and immune system modulation. Epigenetic therapies and small molecule inhibitors are making strides in addressing tumor heterogeneity, while health economics and data management are crucial in assessing drug safety and cost-effectiveness. Machine learning and artificial intelligence are employed to analyze next-generation sequencing data, enabling outcome measurement and post-marketing surveillance.
Patient enrollment is optimized through data-driven strategies, and car T-cell engineering offers promising results in personalized treatments. Liquid biopsy and immune system modulation are key areas of focus in the tumor microenvironment, as genetic mutations are identified and targeted. Overall, the DLBCL therapeutics market is dynamic, with continuous innovation in technology and treatment approaches.

How is this Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Industry segmented?

The diffuse large B-cell lymphoma (DLBCL) therapeutics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Small molecules
  Biologics


Application

  Hospital pharmacy
  Retail pharmacy
  Online pharmacy
  Others


Therapy

  Chemotherapy
  Immunotherapy
  Combination therapies
  Others


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By Product Insights

The small molecules segment is estimated to witness significant growth during the forecast period. The market is witnessing significant growth, driven by advancements in drug development and regulatory approvals. Small molecule drugs, which are low molecular weight organic compounds, play a crucial role in regulating biological processes and are widely used for DLBCL treatment as mono or combination therapy. The market's expansion is fueled by ongoing research in biomarker discovery and genetic profiling, enabling more precise and effective treatments. Regulatory agencies, such as the European Medicines Agency (EMA), are accelerating the approval process for innovative therapies, including immune checkpoint inhibitors and targeted therapies like PD-1 inhibitors and CTL-4 inhibitors. Drug resistance remains a challenge, prompting the development of combination therapies and personalized treatments based on patient genetic profiles.

The market is also witnessing a shift towards targeted therapies and combination treatments, with anti-CD20 antibodies and radiation therapy continuing to be part of the standard of care for DLBCL treatment. The DLBCL therapeutics market is undergoing transformative changes, driven by research, regulatory approvals, and advanc